Comparison of Two Different α1-Adrenoceptor Antagonists, Tamsulosin and Silodosin, in the Treatment of Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective Randomized Crossover Study
Article first published online: 17 AUG 2011
© 2011 Blackwell Publishing Asia Pty Ltd
LUTS: Lower Urinary Tract Symptoms
Volume 4, Issue 1, pages 14–18, January 2012
How to Cite
YOKOYAMA, T., HARA, R., FUJII, T., JO, Y., MIYAJI, Y. and NAGAI, A. (2012), Comparison of Two Different α1-Adrenoceptor Antagonists, Tamsulosin and Silodosin, in the Treatment of Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective Randomized Crossover Study. LUTS: Lower Urinary Tract Symptoms, 4: 14–18. doi: 10.1111/j.1757-5672.2011.00099.x
- Issue published online: 5 JAN 2012
- Article first published online: 17 AUG 2011
- Received 9 June 2011; revised 1 July 2011; accepted 13 July 2011.
- 5Tamsulosin for benign prostatic hyperplasia. Cochrane Database Syst Rev 2003; 1 : CD002081., ,
- 7American Urological Association. Clinical Guidelines: Management of BPH. Chapter 3 with Appendix: Results of the Treatment Outcomes Analysis. 2010. [Cited 26 Jun 2011]. Available from URL:http://www.auanet.org/contnet/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph
- 15Silodosin, a new α1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase 3 randomized, placebo-controlled, double-blind study in Japanese men. BJU Int 2006; 98: 1019–24., ,
- 16Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). BJU Int. DOI: 10.1111/j.1464-410X.2011.10233.x., , et al.